All Stories

  1. Global Evolution of Microbiological Patterns and Pharmacological Guidance in the Management of Peritoneal Dialysis-Associated Peritonitis: An Evolution of Epidemiology and Clinical Practice
  2. 380.1: Validation of a novel non-invasive method based on evaluating urinary exfoliated proximal tubule kidney cell multispectral autofluorescence to differentiate between causes of kidney transplant complications.
  3. 382.2: Evaluating urinary volatile organic compounds as a novel metabolomic biomarker to differentiate between acute tubular necrosis and acute graft rejection following kidney transplantation.
  4. Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper
  5. Utilizing urinary single-cell RNA sequencing to explore the pathogenesis of diabetic kidney disease progression
  6. From Genes to Membrane Failure: Genetic Determinants of Peritoneal Dialysis Physiology and Outcomes
  7. Socioeconomic deprivation and clinical outcomes in patients receiving peritoneal dialysis: A 10-year propensity score matched cohort study from the United Kingdom
  8. Intravenöse Eisenverwendung bei chronischer Nierenerkrankung
  9. Pillar or poison? evaluating overdose and safety challenges in newer diabetic kidney disease medications
  10. Exfoliated kidney cells from urine for non-invasive kidney transplant monitoring: A potential opportunity?
  11. Human Metapneumovirus Infection in Kidney Transplant Recipients
  12. Kidney Transplantation In The Era of Climate Change: Environmental, Structural, and Ethical Implications for Future-Ready Practice
  13. Late-onset lupus nephritis: what is the evidence?
  14. Urinary proteomic profiling to identify early biomarkers of non-diabetic chronic kidney disease
  15. Insights From the UK on Fibromuscular Dysplasia in Pregnancy
  16. Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
  17. Cardiorenal Syndrome in the Elderly: Challenges and Considerations
  18. Gum Hyperplasia in a Patient with Lupus Nephritis
  19. Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
  20. Anti-nuclear cytoplasmic antibody-associated vasculitis and kidney cancer: A mini review
  21. Noninvasive Assessment of Urinary Exfoliated Proximal Tubule Cell Multispectral Autofluorescence May Differentiate between Causes of Kidney Transplant Dysfunction
  22. Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease
  23. Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community
  24. Does Dialysis Modality Have a Role on Stroke Risk?
  25. Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?
  26. Monkeypox infection in kidney transplant recipients
  27. WCN25-79 NON-INVASIVE DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY MACHINE-LEARNING BASED EVALUATION OF URINARY EXFOLIATED PROXIMAL TUBULE CELL MULTISPECTRAL AUTOFLUORESCENCE
  28. Association Between Glycemic Control and Complications With Concentration of Urinary Exfoliated Proximal Tubule Kidney Cells in People With Diabetes Mellitus
  29. Pericardial cyst: an unexpected diagnosis in a patient presenting with breathlessness
  30. H5N1 Infection and Kidney Pathology: Is There a Link?
  31. Considering kidney replacement therapy initiation based on acute encephalopathy in severe acute kidney injury
  32. Characteristics of Inherited Metabolic Disorders Following Kidney Transplantation: A 13-Year Observational Study
  33. Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression
  34. Associations between frailty status and humoral response to SARS-cov-2 vaccination in kidney transplantation and dialysis
  35. Gut Microbiota in Patients Receiving Dialysis: A Review
  36. Lessons for the clinical nephrologist: fibromuscular dysplasia in older adults
  37. Infective Endocarditis in Patients Receiving Hemodialysis: A Current Review
  38. Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy
  39. 499-P: Association between Diabetic Retinopathy and Number of Urinary Exfoliated Proximal Tubule Kidney Cells
  40. Evaluating the Clinical Relevance of Antibodies against Non-Human Leukocyte Antigen in Kidney Transplantation
  41. Autosomal Dominant Polycystic Kidney Disease in Older Adults
  42. #328 Non-invasive assessment of urinary exfoliated proximal tubule cells using multispectral autofluorescence imaging features for early detection of CKD
  43. The Significance of Anti-PLA2R in Diabetic Kidney Disease: Truly a False Positive?
  44. WCN24-213 DIABETIC KIDNEY DISEASE AND NUMBER OF URINARY EXFOLIATED PROXIMAL TUBULE CELLS: IS THERE A LINK?
  45. Incidence, Risk Factors, and Outcomes of De Novo Malignancy following Kidney Transplantation
  46. Using Digital Health Interventions to Promote Prehabilitation Prior to Kidney Transplantation
  47. Clostridioides difficile Infection in Kidney Transplant Recipients
  48. Updates on Renal Replacement Therapy
  49. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?
  50. Hypertrophic Cardiomyopathy and Chronic Kidney Disease: An Updated Review
  51. Is home dialysis an optimal option during pregnancy?
  52. Frailty and antineutrophil cytoplasmic antibody‐associated vasculitis: What do we know?
  53. Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease
  54. How I Treat Elderly Patients with Kidney Failure with Peritoneal Dialysis
  55. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes
  56. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  57. Weighing up telehealth for older adults receiving home dialysis
  58. The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?
  59. COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?
  60. Delivering Personalized, Goal-Directed Care to Older Patients Receiving Peritoneal Dialysis
  61. #4146 LIMITATIONS AND UNCERTAINTIES OF ASSESSING AND MANAGING OLDER PATIENTS WITH ANCA ASSOCIATED VASCULITIS
  62. #5507 ANTIHYPERTENSIVE PRESCRIBING PATTERNS IN CKD: FINDINGS FROM THE SALFORD KIDNEY STUDY
  63. Seizures and chronic kidney disease: An in-depth review
  64. Physiological Associations between Vitamin B Deficiency and Diabetic Kidney Disease
  65. COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review
  66. Big Data in Chronic Kidney Disease: Evolution or Revolution?
  67. Is It Time to Integrate Frailty Assessment in Onconephrology?
  68. Prescribing Immunosuppressive Treatment for Older People with Glomerular Diseases: Time to Assess Frailty?
  69. Merkel Cell Carcinoma in Kidney Transplant Recipients
  70. Stenotrophomonas maltophilia: A Case Series and Review for an Uncommon Cause of Peritoneal Dialysis-Associated Infection
  71. Impact of frailty status on clinical outcomes in patients receiving peritoneal dialysis
  72. Peritoneal dialysis‐associated peritonitis presenting with Ralstonia pickettii infection: A novel series of three cases during the COVID‐19 pandemic
  73. Improving physical functioning and activity of elderly peritoneal dialysis patients
  74. COVID-19 and hepatorenal syndrome
  75. Home dialysis in older adults: challenges and solutions
  76. Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review
  77. Pruritus in Chronic Kidney Disease: An Update
  78. Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?
  79. Exfoliated Kidney Cells from Urine for Early Diagnosis and Prognostication of CKD: The Way of the Future?
  80. MO245: Risk Factors for Venous Thrombosis in ANTI-PLA2R + VE AND−VE Primary Membranous Nephropathy: A 6-YEAR Retrospective Analysis
  81. MO480: Predictive Ability of Clinical Assessment Tools For >2 Weeks in-Hospital Stay Following Hip Fracture in Patients Living With CKD: Insights From a 7-Year Prospective Analysis
  82. MO699: Investigating Longer Term Antibody Response Following Covid-19 Vaccination in Patients Receiving Peritoneal Dialysis—a Single-Center Observational Study
  83. Kidney Replacement Therapy in the Intensive Care Unit
  84. Long‐term antibody response following COVID‐19 vaccination in patients receiving peritoneal dialysis
  85. Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
  86. Quality assessment on the delivery of acute kidney replacement therapy in intensive care
  87. Indications and timing of renal replacement therapy initiation in the intensive care unit: An updated review
  88. UNEXPECTED FINDING OF SINGLE BIFID PAPILLARY MUSCLE ANOMALY IN A PATIENT PRESENTING WITH ANGINA PECTORIS
  89. Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
  90. POS-318 PREDICTIVE ABILITY OF CLINICAL ASSESSMENT TOOLS FOR DELIRIUM FOLLOWING HIP FRACTURE IN PATIENTS LIVING WITH CKD: INSIGHTS FROM A 7-YEAR PROSPECTIVE ANALYSIS
  91. POS-489 RITUXIMAB VERSUS MODIFIED PONTICELLI REGIMEN IN THE MANAGEMENT OF MEMBRANOUS NEPHROPATHY: OUTCOMES FROM A 24-MONTH OBSERVATIONAL ANALYSIS
  92. To What Extent Does Frailty Influence the Risk of Developing Urolithiasis?
  93. Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
  94. Frailty assessment in ANCA-associated vasculitis: current evidence and remaining uncertainties
  95. Concurrent presentation of IgG4-related tubulointerstitial nephritis and ANCA MPO crescentic glomerulonephritis
  96. Vitamin B12 and chronic kidney disease
  97. Intrinsic Kidney Pathology Following COVID-19 Infection in Children and Adolescents: A Systematic Review
  98. Acute interstitial nephritis following SARS-CoV-2 vaccination
  99. An Unusual Cause of AKI in a Kidney Transplant Patient with Merkel Cell Cancer
  100. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review
  101. New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: A Systematic Review
  102. Etanercept-Induced Anti-Glomerular Basement Membrane Disease
  103. Is home hemodialysis a practical option for older people?
  104. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  105. MO090TRANSPLANT KIDNEY BIOPSY FINDINGS IN COVID-19: A SYSTEMATIC REVIEW
  106. MO1039HEALTH PROFESSIONAL PERSPECTIVES OF FRAILTY STATUS EVALUATION DURING PRE-TRANSPLANT ASSESSMENT
  107. MO533WHICH PARAMETERS BEST PREDICT POSITIVE COVID-19 STATUS FOLLOWING HIP FRACTURE FOR PATIENTS LIVING WITH CKD?
  108. ASPERGILLUS PROSTHETIC VALVE ENDOCARDITIS PRESENTING WITH ACUTE VISUAL LOSS IN AN IMMUNOCOMPETENT PATIENT
  109. POS-348 Predicting difficulties with direct home discharge following hip fracture for patients living with CKD: Insights from a 6-year prospective study
  110. POS-349 WHICH PARAMETERS BEST PREDICT REHOSPITALIZATION FROM A SECOND HIP FRACTURE EVENT FOR PATIENTS LIVING WITH CKD ADMITTED FOLLOWING HIP FRACTURE? A 6-YEAR PROSPECTIVE ANALYSIS
  111. Prognostic performance of clinical assessment tools following hip fracture in patients with chronic kidney disease
  112. Dexamethasone in Hospitalized Patients with Covid-19
  113. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  114. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
  115. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  116. Frailty and the Potential Kidney Transplant Recipient: Time for a More Holistic Assessment?
  117. Primary Ewing Sarcoma of the Lung: A Challenging Case
  118. Patient safety and the role of the Helsinki Declaration on Patient Safety in Anaesthesiology
  119. Effect of delayed secondary care referral on morbidity and mortality in idiopathic pulmonary fibrosis patients treated with antifibrotics
  120. An atypical presentation of subacute cutaneous lupus erythematous
  121. Survival after non-resection of colorectal cancer: the argument for including non-operatives in consultant outcome reporting in the UK
  122. Will endoscopic submucosal dissection (ESD) become the gold standard for laterally spreading tumors (LST)?
  123. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
  124. Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637
  125. Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?
  126. AB0996 Bone mineral density at different sites as a predictor of rib fractures: a case-control study
  127. Poster Abstracts
  128. Poster Abstracts
  129. PWE-326 Extending the scope of tem – effect of radiotherapy on outcome in locally excised t2 rectal cancer